Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -166,396 | -68,098 | -248,705 | -192,198 | -118,869 |
| Depreciation Amortization | -4,122 | -1,044 | 6,578 | 6,571 | 5,299 |
| Income taxes - deferred | N/A | N/A | -419 | -296 | N/A |
| Accounts receivable | 2,163 | 678 | 1,256 | 989 | 305 |
| Accounts payable and accrued liabilities | 7,584 | -1,050 | 7,288 | 8,795 | -1,444 |
| Other Working Capital | 18,326 | -2,949 | -13,070 | 411 | -12,067 |
| Other Operating Activity | 12,933 | 10,072 | 22,671 | 13,115 | 15,900 |
| Operating Cash Flow | $-129,512 | $-62,391 | $-224,401 | $-162,613 | $-110,876 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -36,671 | 5,754 | -13,300 | -9,072 | 110,841 |
| PPE Investments | -2,877 | -1,758 | -10,816 | -7,940 | -4,415 |
| Investing Cash Flow | $-39,548 | $3,996 | $-24,116 | $-17,012 | $106,426 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 388,835 | 324,205 | 301,390 | 250,069 | 1,734 |
| Other Financing Activity | 0 | 0 | 42 | 0 | 0 |
| Financing Cash Flow | $388,835 | $324,205 | $301,432 | $250,069 | $1,734 |
| Beginning Cash Position | 163,149 | 163,149 | 110,234 | 110,234 | 110,234 |
| End Cash Position | 382,924 | 428,959 | 163,149 | 180,678 | 107,518 |
| Net Cash Flow | $219,775 | $265,810 | $52,915 | $70,444 | $-2,716 |
| Free Cash Flow | |||||
| Operating Cash Flow | -129,512 | -62,391 | -224,401 | -162,613 | -110,876 |
| Capital Expenditure | -2,877 | -1,758 | -10,816 | -7,940 | -4,415 |
| Free Cash Flow | -132,389 | -64,149 | -235,217 | -170,553 | -115,291 |